Exelixis Outlines Growth Strategy as CABOMETYX Franchise Reaches $2.12B, Zanzalintinib Launch by 2026
Source link
SMIC increases wafer capacity while new equipment increases depreciation
SMIC increases wafer capacity while new equipment increases depreciation Source link







